| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $633K | +128.7% |
| R&D Expense | $423K | +2135.5% |
| SG&A Expense | $3.0M | +38.4% |
| Operating Income | -$6.4M | -29.9% |
| Pre-tax Income | -$6.4M | -29.7% |
| Net Income | -$6.4M | -29.7% |
| EPS (Basic) | -$1.70 | -372.2% |
| EPS (Diluted) | -$1.70 | -372.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $2.7M | -8.9% |
| Total Assets | $3.2M | +4.6% |
| Current Liabilities | $431K | +180.6% |
| Total Liabilities | $431K | +180.6% |
| Stockholders' Equity | $2.8M | -4.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | -28.7% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$400K | -252.2% |
| Financing Cash Flow | $5.0M | -24.9% |
| Free Cash Flow | -$4.9M | -28.6% |